Anju T Peters
Anju T Peters is an expert in Allergy at Northwestern University (United States) (United States). As of October 2026, ScienceLeadR ranks Anju T Peters in the top 1% of experts worldwide for Sinusitis, Rhinosinusitis and Nose Diseases. Anju T Peters has authored 341 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 2 of them ongoing. SLR score: 1,245 (community average: 125). How the SLR is computed.
LeadR Profile
Allergy
Subspecialties: Immunology - Otolaryngology - Pulmonology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2008 - 2026
Number : 341
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Efficacy of Exhalation Delivery System With Fluticasone in Chronic Rhinosinusitis With Versus Without Polyps. PMID 42647052 — exhalation, smell, fluticasone, polyps, signs and symptoms, therapeutics, nasal polyps, rhinosinusitis | Otolaryngol Head Neck Surg | 2026 | 0 |
| Reply to: Malik MMUD on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT). PMID 42599686 — smell, hypersensitivity, polyps, therapeutics, nasal polyps, rhinosinusitis | Int Forum Allergy Rhinol | 2026 | 0 |
| Dupilumab effectiveness and safety in patients with CRSwNP: two year results from AROMA registry. PMID 42508565 — registries, quality of life, safety, hypersensitivity, signs and symptoms, immunity, asthma | Ann Allergy Asthma Immunol | 2026 | 0 |
| High Systemic Corticosteroids Burden Among Moderate-to-Severe Asthma Patients in the United States. PMID 42448101 — hypersensitivity, adrenal cortex hormones, prescriptions, immunity, asthma, steroids | Ann Allergy Asthma Immunol | 2026 | 0 |
| The role, evaluation, and effects of comorbidities in patients with chronic rhinosinusitis. PMID 42386153 — comorbidity, hypersensitivity, cystic fibrosis, therapeutics, bronchiectasis, granulomatosis with polyangiitis, rhinosinusitis | J Allergy Clin Immunol Pract | 2026 | 0 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| CRS Questionnaire Validation Project NCT06970977 — polyps, nasal polyps, rhinosinusitis | N/A | Recruiting | 2024 |
| Study Assessing Long teRm Outcomes of dupiluMAb (DUPIXENT ) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) NCT04959448 — quality of life, comorbidity, physicians, health personnel, therapeutics, rhinosinusitis | N/A | Active not recruiting | 2021 |
LeadR Networks
Main global connection map